Result Summary for S2WA4005
| Protocol ID: | S2WA4005 |
| Clinical Study ID: | S2WA4005 |
| Official Title: | A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Evaluation of Oral Naratriptan (2.5mg) Administered Twice Daily in the Treatment of Transformed Migraine. |
| Phase: | Phase 4 |
| Study Indications or Diseases: |
|
| Generic Name: | naratriptan |
| Trade/Product Name: | amerge;naramig |
| Approved Drug Label: | http://www.gsk.com/products.html |
| Results Summary: |  Click
here to download result summary. |
| Citations: |
|
The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.
